Gerald L. Hogue - Net Worth and Insider Trading

Gerald L. Hogue Net Worth

The estimated net worth of Gerald L. Hogue is at least $45,750 dollars as of 2024-05-25. Gerald L. Hogue is the Director of POINT Biopharma Global Inc and owns about 3,660 shares of POINT Biopharma Global Inc (PNT) stock worth over $45,750. Details can be seen in Gerald L. Hogue's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Gerald L. Hogue has not made any transactions after 2022-11-25 and currently still holds the listed stock(s).

Transaction Summary of Gerald L. Hogue

To

Gerald L. Hogue Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Gerald L. Hogue owns 1 companies in total, including POINT Biopharma Global Inc (PNT) .

Click here to see the complete history of Gerald L. Hogue’s form 4 insider trades.

Insider Ownership Summary of Gerald L. Hogue

Ticker Comapny Transaction Date Type of Owner
PNT POINT Biopharma Global Inc 2022-11-25 director

Gerald L. Hogue Latest Holdings Summary

Gerald L. Hogue currently owns a total of 1 stock. Gerald L. Hogue owns 3,660 shares of POINT Biopharma Global Inc (PNT) as of November 25, 2022, with a value of $45,750.

Latest Holdings of Gerald L. Hogue

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
PNT POINT Biopharma Global Inc 2022-11-25 3,660 12.50 45,750

Holding Weightings of Gerald L. Hogue


Gerald L. Hogue Form 4 Trading Tracker

According to the SEC Form 4 filings, Gerald L. Hogue has made a total of 1 transactions in POINT Biopharma Global Inc (PNT) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in POINT Biopharma Global Inc is the acquisition of 3,660 shares on November 25, 2022, which cost Gerald L. Hogue around $24,961.

Insider Trading History of Gerald L. Hogue

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Gerald L. Hogue Trading Performance

GuruFocus tracks the stock performance after each of Gerald L. Hogue's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Gerald L. Hogue is 11.34%. GuruFocus also compares Gerald L. Hogue's trading performance to market benchmark return within the same time period. The performance of stocks bought by Gerald L. Hogue within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Gerald L. Hogue's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Gerald L. Hogue

Average Return

Average return per transaction

Outperforming Transactions

1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 2.69
Relative Return to S&P 500(%) 7.19

Gerald L. Hogue Ownership Network

Ownership Network List of Gerald L. Hogue

No Data

Ownership Network Relation of Gerald L. Hogue


Gerald L. Hogue Owned Company Details

What does POINT Biopharma Global Inc do?

Who are the key executives at POINT Biopharma Global Inc?

Gerald L. Hogue is the director of POINT Biopharma Global Inc. Other key executives at POINT Biopharma Global Inc include other: See Explanation of Responses Biotechnology Value Fund L P , 10 percent owner Bvf Partners L P/il , and 10 percent owner Bvf Gp Holdings Llc .

POINT Biopharma Global Inc (PNT) Insider Trades Summary

Over the past 18 months, Gerald L. Hogue made no insider transaction in POINT Biopharma Global Inc (PNT). Other recent insider transactions involving POINT Biopharma Global Inc (PNT) include a net sale of 17,161,278 shares made by Biotechnology Value Fund L P , a net purchase of 3,700 shares made by Rajesh Malik , and a net purchase of 2,160 shares made by Joe A. Mccann .

In summary, during the past 3 months, insiders sold 0 shares of POINT Biopharma Global Inc (PNT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 17,161,278 shares of POINT Biopharma Global Inc (PNT) were sold and 5,860 shares were bought by its insiders, resulting in a net sale of 17,155,418 shares.

POINT Biopharma Global Inc (PNT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

POINT Biopharma Global Inc Insider Transactions

No Available Data

Gerald L. Hogue Mailing Address

Above is the net worth, insider trading, and ownership report for Gerald L. Hogue. You might contact Gerald L. Hogue via mailing address: 4850 West 78th Street, Indianapolis In 46268.

Discussions on Gerald L. Hogue

No discussions yet.